South-East Asia Region
Dr Catharina Boehme
Officer-in-Charge, WHO South-East Asia Region
In 2024–2025, the WHO South-East Asia Region delivered measurable progress across priority outcomes and advanced the WHO Results Framework through strong country ownership, focused collaboration, and sustained technical cooperation.
Member States advanced the elimination and control of communicable diseases. Maldives achieved triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B. Timor Leste secured malaria-free certification, and Bhutan qualified for malaria-free certification after sustaining zero indigenous cases for three consecutive years. Countries expanded immunization coverage, reduced zero-dose children, and Nepal became the sixth country in the Region to eliminate rubella.
Countries strengthened emergency preparedness and response through coordinated approaches to detection, readiness and rapid action. They advanced public health intelligence, event-based surveillance and IHR-aligned risk assessment, enabling early detection and timely, evidence informed decision-making. DPR Korea intensified preparedness through Preparedness and Resilience for Emerging Threats (PRET) aligned simulation and planning. In Myanmar, the WHO led Health Cluster delivered services to 2.2 million people. WHO strengthened surge capacity through the Regional Health Emergency Workforce Strategy (2025–2030) and reinforced laboratory and genomic surveillance.
Member States accelerated primary health care reforms under the Delhi Declaration, advancing universal health coverage through improved financing, workforce development and regulatory systems. They also advanced digital health transformation by strengthening governance and regulatory readiness and promoting interoperable, investment-ready systems.
Through the SEAHEARTS 2025 initiative, Member States expanded prevention and care for noncommunicable diseases. Countries demonstrated leadership through initiatives such as the generational tobacco ban in Maldives, accelerating the scale-up of standardized treatment for hypertension and diabetes through the 75/25 Initiative in India, multisectoral engagement in Bangladesh, HPV vaccine scale-up, Arogya health and wellness centres in Sri Lanka, and strengthened injury surveillance in Thailand.
Despite constrained financing, humanitarian crises and climate-related health impacts, Member States and WHO sustained progress. Looking ahead, WHO and Member States shaped the Programme Budget 2026–2027 through a structured, country-driven process. Together, they have established the Banyan Framework for health and wellbeing to anchor this next phase of work. Rooted in country ownership and strengthened through partnership, the Framework will guide the Region to deliver greater, sustained impact at scale.
I thank all Member States for their continued leadership and commitment. EOBA 2024–2025 reflects a Region delivering results with coherence, efficiency and impact.
PROGRESS ON THE TRIPLE BILLION TARGETS
Regional Aggregation
These charts illustrate the contributions of various tracer indicators driving progress toward the Triple Billion targets for universal health coverage, health emergencies and healthier populations. Each stacked bar shows the relative contribution of these indicators over time, highlighting both gains and areas where progress has reversed. The overlaid lines indicate the net impact of outcome indicators associated with each target, providing a broader view of how health impact is evolving.
WHO CONTRIBUTION TOWARDS HEALTH OUTCOMES
Regional Aggregation Of The Output Prioritization
This table provides a regional overview of the financing and implementation of prioritized outputs. It presents planned costs, available funds and utilization, alongside the number of offices (countries, territories and areas) that have identified each output as high or medium priority.
OUTPUT SCORECARDS
WHO’s Output Scorecard Measures Its Performance For Accountability
These scorecards provide an overview of progress in the delivery of outputs across the Region. Performance is assessed across six dimensions, each with specific criteria for technical and enabling outputs. Select an outcome to explore the related scorecards.
HIGHLIGHTED RESULTS
Explore WHO’s Contribution To Health Outcomes Across the Region
- Universal health coverage
- Health emergencies protection
- Healthier populations
- Effective and efficient WHO
-
SE-1_Advancing PHC Reform Through Regional Leadership, Peer Learning, and Policy Accountability
The South-East Asia Regional primary health care (PHC) Forum has been instrumental in advancing knowledge exchange and peer-to-peer collaboration across Member States, translating regional commitments into operational reforms. Anchored in the WHO South-East Asia Regional Primary Health Care Strategy 2022–2030 and the 2023 Ministerial Delhi Declaration on Strengthening Primary Health Care, the WHO Regional Office for South-East Asia provided a unifying framework to accelerate PHC-oriented reforms across diverse country contexts. In 2025, WHO strengthened operationalization through sustained regional convening, targeted country support, and presentation of the first progress report on the Delhi Declaration to the seventy-eighth session of the WHO Regional Committee for South-East Asia. The report documented advances in PHC financing, governance, social participation, health workforce, access to quality medical products, service delivery reorientation, digital health, and PHC monitoring, drawing on rapid health systems assessments conducted in seven Member States.The Regional PHC Forum, now in its third year, was consolidated as a core platform for regional learning and accountability. Regular weekly and monthly virtual engagements were complemented by country-focused initiatives, including the Sri Lanka edition of the WHO Academy PHC Leadership Course, support to Nepal’s PHC dialogue series, and the launch of the Maldives universal health coverage (UHC) Forum. Maldives was further supported to join the WHO Health Impact Investment Platform, marking the first engagement of a Member State in the Region. WHO convened the fourth annual Regional PHC Forum in Kathmandu in December 2025, resulting in a shared roadmap for 2026 focused on expanding access to quality PHC for remote and underserved populations. A high-level session at the World Health Summit 2025 reinforced cross-country exchange on large-scale PHC reforms and strengthened partner alignment.At country level, the Forum contributed to PHC leadership and management initiatives in Maldives and Sri Lanka, supported multidisciplinary team building in PHC in Thailand, and advanced development of UHC and PHC knowledge platforms in Bhutan, Maldives and Nepal. WHO further strengthened the evidence base through publication of a cross-country synthesis on PHC during coronavirus disease (COVID-19), informing future system strengthening across the Region. Collectively, these outputs enhanced regional accountability, strengthened national capacity, and supported PHC reforms as the foundation for UHC. -
SE-1_Driving Progress on Communicable Diseases: South-East Asia Region’s Historic Path to Elimination
Home to a quarter of the global population, the South-East Asia Region bears a disproportionate communicable disease burden: 34% of global tuberculosis (TB) incidence, over half of TB deaths, and 54% of the neglected tropical diseases (NTD) burden. It is the second-largest contributor to global malaria and faces specific burdens of viral hepatitis (24%), sexually transmitted infections (STIs) (16%), human immunodeficiency virus (HIV) (10%), and antimicrobial resistance.During the 2024–2025 biennium, the Secretariat accelerated progress by providing intensive technical leadership and rigorous validation for countries reaching elimination. WHO’s contribution centred on strengthening health systems through high-quality technical support, capacity-building, monitoring and evaluation, quality assurance, and high-level advocacy to foster ownership. Among the technical support provided were cross-border collaboration activities for disease elimination and integrated programme reviews for related diseases, which streamlined data collection and improved quality assurance by standardizing surveillance across overlapping technical requirements. These reviews achieved significant operational efficiencies by replacing siloed evaluations with a holistic view of national health systems and generated substantial cost and time savings. Key examples include: integrated vector-borne disease (VBD) reviews in Sri Lanka, with a single review covering malaria, dengue, filariasis and leishmaniasis; a review in Bhutan combining the same diseases except filariasis; and a joint assessment in Myanmar covering malaria and dengue.These efforts contributed to frontline achievements in 2024–2025 in eliminations and WHO certifications, marking a definitive shift from “control” to “elimination” and consolidating progress from previous years:• India: Officially validated for the elimination of trachoma as a public health problem.• Timor-Leste: Successfully achieved the elimination of lymphatic filariasis (LF) as a public health problem in 2024.• Timor-Leste: Officially received WHO malaria-free certification in 2025 after achieving zero indigenous transmission.• Maldives: Verified for the historic interruption of leprosy transmission in 2025.• Maldives: Became the first country globally to achieve “triple elimination” of mother-to-child transmission of HIV, syphilis and hepatitis B.• Bhutan: Now eligible for malaria-free certification after reporting zero indigenous cases for three consecutive years. -
SE-1_From Capacity to Confidence: Strengthening Vaccine Regulation and Pandemic Readiness in South East Asia
During the 2024–2025 biennium, WHO provided coordinated strategic and technical support to strengthen vaccine regulatory systems across the South-East Asia Region, with a focus on regulatory maturity, pandemic preparedness and continuity of essential regulatory functions. Addressing gaps exposed during the coronavirus disease (COVID-19) pandemic, regulatory system strengthening was prioritized as a core enabler of vaccine equity, emergency response and regional manufacturing resilience.At the country level, WHO support resulted in concrete progress. In Bhutan, WHO supported a review of the Druk Centre for Testing and Regulation and initiated discussions towards establishing a regional centre of excellence for regulatory training. In India, the country successfully retained WHO Global Benchmarking Tool (GBT) Maturity Level 3 for vaccine regulation, ensuring sustained international confidence and uninterrupted eligibility to supply vaccines to United Nations (UN) agencies and global markets. Targeted technical assistance was provided to the Central Drugs Standard Control Organization (CDSCO) to sustain regulatory maturity and preparedness. In Nepal, follow-up support was provided to implement institutional development plans and corrective actions following assisted self-benchmarking. Preparatory work was also initiated to support Indonesia’s National Agency of Drug and Food Control (BPOM) in progressing towards potential WHO-Listed Authority (WLA) recognition. WHO also facilitated regulatory collaboration linked to the WHO Medicines Patent Pool (MPP) messenger ribonucleic acid (mRNA) Technology Transfer Programme, involving manufacturers in Bangladesh, India and Indonesia.At the regional level, WHO strengthened preparedness through the rollout of the 100-day national regulatory authority (NRA) agenda, enhancing emergency authorization, lot release surge capacity, inspections and regulatory workforce readiness. Regulatory convergence was advanced through capacity-building in good reliance practices, regulatory performance indicators and advanced inspections, and collaboration was reinforced through the South-East Asia Regulatory Network (SEARN). Hosting the nineteenth International Conference of Drug Regulatory Authorities (ICDRA) in 2024 positioned the Region as a leader in global regulatory dialogue. Collectively, these results strengthened regulatory resilience, improved pandemic preparedness, and enabled faster, more equitable access to quality-assured vaccines. -
SE-1_SEAHEARTS 2025 Delivers: Stronger Systems, Better Prevention and Care, Healthier Hearts.
The South-East Asia HEARTS (SEAHEARTS) 2025 initiative was launched to strengthen the prevention and control of cardiovascular diseases across the Region. The Secretariat significantly advanced SEAHEARTS 2025 by guiding countries in implementing WHO technical packages—HEARTS, MPOWER, SHAKE and REPLACE—which led to the initiation of several prioritized policy and clinical intervention measures. By June 2025, more than 94 million people with hypertension and diabetes had been placed in protocol-based management. Over 184 000 public health care facilities have adopted drug- and dose-specific treatment protocols and digital monitoring systems to track outcomes for hypertension and diabetes. An estimated 2.08 billion people were covered by at least one national salt reduction policy, and 2.03 billion people were potentially protected from the harmful effects of industrially produced trans fatty acids through best-practice trans fatty acid regulations.The Secretariat facilitated the building of political momentum through advocacy and technical support, resulting in the Dhaka Call to Action and the Colombo Call to Action. National roadmaps were developed using recent hypertension and diabetes care data to set baselines, targets and projected treatment scenarios for 2025. The Secretariat facilitated the sharing and exchange of best practices on the implementation of SEAHEARTS interventions, along with targeted technical assistance in implementing evidence-based management protocols, improving availability of protocol medicines and diagnostics, and strengthening information systems.In addition, WHO led regional efforts to advance policies addressing unhealthy diets by promoting the elimination of industrial trans fats and reducing population salt intake. The Organization updated its nutrient profile model to guide stronger, evidence-based policies across the Region. As no other agency was working in these areas, WHO served as the primary technical authority supporting countries throughout the entire policy cycle.Creation of the SEAHEARTS monitoring platform contributed to advocacy and technical monitoring of risk reduction policy measures and treatment coverage of hypertension and diabetes. It provided a biannual mechanism to track and report countries’ progress, enabling more timely review and response. The establishment of this platform has further strengthened regional action by improving coordination, transparency and accountability.These contributions strengthened coordination and increased commitment to evidence-based noncommunicable disease (NCD) measures. As a result, countries are better equipped to improve hypertension and diabetes control, scale tobacco control, reduce population salt intake, and eliminate trans fats through evidence-based strategies, and expand primary health care (PHC)-based NCD services. -
SE-2_Advancing Multisource Collaborative Surveillance in WHO South East Asia Region: Improving Decision Making to Protect People from Health Emergencies.
Managing health emergencies requires timely, critical decision-making amid significant uncertainty. Lessons from the coronavirus disease (COVID-19) pandemic and other crises underscore that effective decisions must be informed by multiple sources of information. However, systematically accessing, synthesizing and using multisource information remains a persistent challenge in many countries.The WHO Regional Office for South-East Asia (SEARO) developed a six-step approach to strengthen multisource collaborative surveillance (MSCS), engaging Member States and all three levels of WHO. Bangladesh applied MSCS methods for influenza and other respiratory pathogen surveillance, engaging multisectoral stakeholders to review surveillance maturity assessments and deciding to advance a One Health approach, integrating human, animal and environmental health data. Indonesia (before reassignment to the WHO Western Pacific Region) was the pioneer in implementing MSCS to improve dengue surveillance and developed an integrated analytics team and dashboard using epidemiological, laboratory and climate data to inform dengue control; Indonesia continues to apply MSCS for other diseases. Nepal used water-borne and food-borne diseases as an entry point to operationalize an alert and response framework and to advance an interoperable information platform.These experiences were shared through the Regional Meeting to Advance MSCS in the WHO South-East Asia Region (March 2025). Incorporating countries’ experiences and lessons, SEARO published a regional manual, Informing public health decision-making with multisource collaborative surveillance: a step-by-step approach, in August 2025.Other countries are also applying the MSCS approach to strengthen their surveillance systems. In Sri Lanka, work is under way towards an integrated surveillance platform, enhancing digitalization and interoperability to enable data exchange across health care facilities, laboratories and various disease control programmes. In Thailand, MSCS was applied to the disaster management cycle, developing an online platform and enhancing interoperability of situation awareness teams across the Ministry of Public Health.Experience to date confirms that MSCS is an effective investment to improve decision-making and better manage health emergencies. The process requires thinking backwards from decision questions to surveillance objectives and then to surveillance approaches. Enhancement of MSCS requires strong leadership, sustained multisectoral coordination and collaborative approaches to surveillance in each country context. -
SE-2_Outbreak to Control: Strengthening Cholera Preparedness and Rapid Response in South East Asia to Save Lives
During the 2024–2025 biennium, the WHO South-East Asia Region delivered critical results in strengthening cholera preparedness, outbreak detection and rapid response across highly vulnerable and humanitarian settings. Cholera continued to pose a major public health threat in the Region due to flooding, displacement, poor water, sanitation and hygiene (WASH) infrastructure, population mobility and fragile health systems. Large-scale outbreaks in Bangladesh and Myanmar, combined with global cholera resurgence and intermittent constraints in oral cholera vaccine (OCV) supply, placed significant pressure on national and regional response capacities.In this challenging context, WHO prioritized early detection, coordinated outbreak response and targeted OCV deployment, aligned with the global Ending Cholera – A Global Roadmap to 2030. WHO provided leadership through incident management coordination, strengthened surveillance and risk assessment, and supported Member States in evidence-based decision-making through national immunization technical advisory groups (NITAGs) and expanded programme on immunization (EPI) platforms. Technical assistance included cholera mapping, epidemiological analysis, laboratory strengthening, deployment of rapid response teams, and integration of health and WASH interventions.In Bangladesh, WHO support to reactive OCV campaigns in Rohingya refugee camps and surrounding host communities contributed to rapid interruption of transmission. Following vaccination campaigns in early 2025, no culture-confirmed cholera cases were reported after 29 January 2025. Improved early warning systems, preparedness planning and coordinated partner response prevented large-scale outbreaks despite persistent high risk, protecting both displaced and host populations.In Myanmar, WHO supported outbreak response across nine states and regions during 2024–2025, enabling large-scale reactive OCV campaigns that vaccinated more than two million people in a complex humanitarian and conflict-affected setting. Strengthened surveillance and weekly epidemiological analyses improved early detection and guided adaptive response strategies, enhancing national outbreak readiness and operational coordination.The biennium reinforced that OCV is a powerful outbreak control tool but cannot substitute for sustained investments in WASH and long-term cholera prevention. Early detection, timely surveillance and pre-approved outbreak response mechanisms—including advance preparedness for OCV requests through the International Coordinating Group (ICG)—are critical to interrupt transmission rapidly. Strong community engagement and close coordination between health and WASH actors significantly improved campaign acceptance, operational efficiency and equity of response, particularly in humanitarian and high-density settings -
SE-2_Public Health Intelligence in Action: Protecting People from Health Security Threats in WHO South East Asia Region
The WHO South-East Asia Region continues to face diverse and evolving health security threats, making early detection, timely risk assessment and alert mechanisms essential. The Health Emergency Information and Risk Assessment (HIM) team strengthened regional public health intelligence (PHI) capacities to enable early detection and assessment of acute public health events.Throughout 2025, the team screened more than 3 000 media articles daily. Of approximately 1.1 million media articles screened, 3 218 items were filtered for internal assessment, leading to investigation of 219 signals and resulting in 34 events being substantiated as public health events and recorded in WHO’s Event Management System. Together with 25 events sustained from previous years, a total of 59 events were actively monitored in 2025. Event verification and follow-up were conducted in close collaboration with Member States and WHO country offices.International Health Regulations (IHR) event communication was also strengthened, supported by operational duty officer mechanisms, resulting in more active and timely communication. The HIM team contributed to the annual regional simulation exercise on IHR event communication, “SAPHIRE”, which builds trust between States Parties and WHO as a foundation for event communication. The team also published the interim guidance Considerations for strengthening international information sharing for tracing and managing cases and contact persons to optimize information sharing.Public health risks of substantiated events were routinely assessed using the Quick and Immediate Risk Assessment (QIRA) algorithm, while formal rapid risk assessments were conducted for eight events of public health importance. Public health situation analysis was conducted following major disasters, such as the earthquake in Myanmar and a cyclone in Sri Lanka, to guide emergency response.Information on acute health events was disseminated through 15 postings on event information sites and nine articles in Disease Outbreak News, covering events such as Nipah, avian influenza, anthrax and Zika. The Epidemiological Bulletin for the WHO South-East Asia Region was published bi-weekly (52 editions), providing timely updates on key public health threats.The HIM team also invested in building PHI capacities in countries. A training programme on the risk assessment package for Member States was developed, and training was delivered in Bhutan, Maldives and the Association of Southeast Asian Nations (ASEAN) bio-threat surveillance centre. A regional community of practice for PHI was launched in August 2025, aiming to provide continuous education opportunities and a forum for experience sharing. -
SE-4_Country Focus and Transformation Agenda Advanced & Investment in Country Capacity Building Strengthened
The WHO Regional Office for South-East Asia strengthened country office leadership, governance and three-level coordination, advancing both the country focus and the broader transformation agenda. All country cooperation strategies (CCS) were maintained as valid, making the South-East Asia Region the only Region with all valid CCS. During the biennium, three CCS were renewed (Maldives, Myanmar and Sri Lanka), two are in the final stages of approval (Bhutan and Timor-Leste), and one was extended (Bangladesh). Additionally, three country impact stories were featured in the Country Presence Report 2025, which was endorsed at the Seventy-eighth World Health Assembly.In response to global funding constraints, restructuring of WHO country offices was guided by the corporate core country office model (CCOM), ensuring that minimum core capacities are maintained across all offices. This approach strengthened leadership and technical continuity while enabling more differentiated and responsive support to countries based on evolving needs and priorities.WHO also shifted from short-term capacity-building to strategic, longer-term investments aligned with CCS priorities and the Thirteenth and Fourteenth General Programmes of Work (GPW13 and GPW14). Through this approach, 24 fellows from four countries (Bhutan, Maldives, Nepal and Timor-Leste) were supported across eight key public health areas, including field epidemiology, nursing and critical care, laboratory strengthening, infectious diseases, bioinformatics and risk communication. A further 21 fellowships are planned for the 2026–2027 biennium to build and sustain capacity development in priority areas.The Region also strengthened its early-career public health workforce through the Junior Public Health Professionals programme. Eight Junior Public Health Professionals from five countries benefited from enhanced coaching, mentoring and post-training utilization support.These longer-term capacity-building investments, totalling approximately US$ 1.0 million, have strengthened national workforce capacity, improved country readiness and enhanced accountability for results. By prioritizing sustained professional development and stronger country presence, WHO has reinforced its ability to deliver high-quality and continuous technical cooperation to Member States despite a constrained global funding environment. -
SE-4_From Data to Evidence: Strengthening Dengue Surveillance and Research Systems Across South East Asia
The WHO South-East Asia Region continues to face diverse and evolving health security threats, making early detection, timely risk assessment and alert mechanisms essential. The Health Emergency Information and Risk Assessment (HIM) team strengthened regional public health intelligence (PHI) capacities to enable early detection and assessment of acute public health events.Throughout 2025, the team screened more than 3 000 media articles daily. Of approximately 1.1 million media articles screened, 3 218 items were filtered for internal assessment, leading to investigation of 219 signals and resulting in 34 events being substantiated as public health events and recorded in WHO’s Event Management System. Together with 25 events sustained from previous years, a total of 59 events were actively monitored in 2025. Event verification and follow-up were conducted in close collaboration with Member States and WHO country offices.International Health Regulations (IHR) event communication was also strengthened, supported by operational duty officer mechanisms, resulting in more active and timely communication. The HIM team contributed to the annual regional simulation exercise on IHR event communication, “SAPHIRE”, which builds trust between States Parties and WHO as a foundation for event communication. The team also published the interim guidance Considerations for strengthening international information sharing for tracing and managing cases and contact persons to optimize information sharing.Public health risks of substantiated events were routinely assessed using the Quick and Immediate Risk Assessment (QIRA) algorithm, while formal rapid risk assessments were conducted for eight events of public health importance. Public health situation analysis was conducted following major disasters, such as the earthquake in Myanmar and a cyclone in Sri Lanka, to guide emergency response.Information on acute health events was disseminated through 15 postings on event information sites and nine articles in Disease Outbreak News, covering events such as Nipah, avian influenza, anthrax and Zika. The Epidemiological Bulletin for the WHO South-East Asia Region was published bi-weekly (52 editions), providing timely updates on key public health threats.The HIM team also invested in building PHI capacities in countries. A training programme on the risk assessment package for Member States was developed, and training was delivered in Bhutan, Maldives and the Association of Southeast Asian Nations (ASEAN) bio-threat surveillance centre. A regional community of practice for PHI was launched in August 2025, aiming to provide continuous education opportunities and a forum for experience sharing. -
SE-4_From Fragmentation to Interoperability: Advancing National Digital Transformation for Strengthened Health Systems
In 2025, the WHO Regional Office for South-East Asia (SEARO) added strategic value by supporting Member States to transition from fragmented, vertically financed digital initiatives towards nationally governed, interoperable digital health systems aligned with primary health care (PHC) priorities. Rapid expansion of digital solutions had created parallel systems with limited interoperability and underutilized data, constraining countries’ ability to scale innovation sustainably and realize gains towards universal health coverage (UHC). In response, SEARO strengthened national stewardship of digital transformation by supporting the development, validation, formal approval and costing of national digital health blueprints. These processes enabled countries to secure investments and position digital health as a system-wide enabler rather than a programme-specific tool.Concrete results were achieved across the Region. In Bangladesh, the national digital health blueprint was formally approved in 2025, providing a structured framework to guide interoperable investments. In Bhutan, multi-stakeholder workshops advanced consensus on governance and interoperability. In Nepal and Timor-Leste, draft blueprints were finalized through national consultations. WHO-SEARO also supported Georgia in developing its national digital health blueprint and convened a Digital Health Matchmaking Workshop to align priorities with development partners, strengthening coordination and resource mobilization. At regional level, the 2025 Open Digital Health Summit advanced adoption of open standards and digital public infrastructure, reinforcing commitment to reusable, scalable digital public goods supporting PHC.In India, SEARO supported the Ministry of Health and the Indian Council of Medical Research (ICMR) in developing the Strategy for Artificial Intelligence in Healthcare for India (SAHI), positioning India as the first Global South country with a nationally led artificial intelligence (AI)-for-health strategy. Through four regional workshops, the strategy was refined to ensure strong foundations in safety, ethics, governance and health system readiness, creating a pathway for responsible AI adoption. Institutional sustainability was further strengthened through identification of prospective WHO collaborating centres on digital health and formalized partnerships with ICMR–National Institute for Research in Digital Health, Indian Institute of Technology Bombay (IIT Bombay), and the Nepal Applied Mathematics and Informatics Institute.Collectively, these outputs have strengthened governance, improved interoperability, enhanced country ownership, and created investment-ready digital ecosystems—laying the foundation for equitable, efficient and data-driven PHC delivery and accelerating progress towards UHC.
